Phathom Pharmaceuticals, Inc. - 8-K Filing
Phathom Pharmaceuticals reports Q3 2026 net revenues of $84.7 million, up 71% year-over-year, and reaffirms full-year guidance. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $PHAT
Read the full article at SEC EDGAR
Part of the story MOVING iMAGE TECHNOLOGIES INC. - 4 Filing (9097 articles)